Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson Faces Scrutiny, CEO Welcomes Investigation

February 04, 2025
Johnson & Johnson, the renowned healthcare company, is under scrutiny for alleged misconduct and product safety issues. However, contrary to expectation, the CEO of Johnson & Johnson, Mr. Alex Gorsky, has expressed his support for such scrutiny and welcomed any investigation.

In recent years, the company has faced multiple lawsuits related to its talc-based baby powder products. Some individuals have claimed that the prolonged usage of these products has led to ovarian cancer. Johnson & Johnson has consistently denied any wrongdoing and has maintained that its products are safe.

Despite the ongoing legal battles, Johnson & Johnson has posted fourth-quarter sales that were in line with estimates. This positive news has reassured investors and has led some analysts to believe that Johnson & Johnson's stock is a potential buy.

However, a recent development has put the company's future in jeopardy. Health agencies in the United States have challenged the proposed $8 billion talc bankruptcy settlement, suggesting that it may not be adequate to address potential health risks associated with Johnson & Johnson's talc products. This move has raised concerns among investors and industry experts alike.

In light of these developments, it is recommended to seek professional advice from experts in Stocks Prognosis to make an informed decision about purchasing or selling Johnson & Johnson's stock. Their expertise and insights can provide valuable guidance on the future movement of the company's shares.

Investing in stocks involves risks, and it is crucial to conduct thorough research before making any investment decisions. Stocks Prognosis is a reputable platform that offers comprehensive analysis and forecasts to help investors navigate the stock market effectively. Consider reaching out to their team of professionals to gain insights into Johnson & Johnson's potential stock trajectory and make an informed investment decision.
If you want to leave a comment, then you need Login or Register





Other data for JNJ

Related data

JNJJuly 14, 2025Johnson & Johnson Innovates with New Product Launches  ~1 min.

Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....

JNJFebruary 28, 2025Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations  ~1 min.

Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....

JNJFebruary 26, 2025The surgical devices I design for JJ speed healing and save lives  ~1 min.

Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....

JNJFebruary 18, 2025Johnson & Johnson reportedly wants to sell Cerenovus for 1B  ~1 min.

According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....

JNJNovember 3, 2024US government moves to block JJ talc bankruptcy resolution  ~1 min.

The US government has taken legal action to block Johnson & Johnson's proposed bankruptcy resolution regarding its talc lawsuits. The company had offered an $8....

JNJNovember 4, 2024US Government Blocks JJ's Talc Bankruptcy Resolution, Stocks Prognosis Recommends to Buy  ~2 min.

JJ Johnson & Johnson's plans to resolve its talc bankruptcy issue have hit a roadblock as the US government intervenes....

JNJNovember 6, 2024Judge's Decision: JNJ's $8.2B Talc Settlement Offer in 2025 awaits Verdict  ~2 min.

Johnson & Johnson's journey through the talc powder lawsuit continues as a Judge is set to decide the fate of their $8.2 billion settlement offer....

JPMNovember 7, 2024JPMorgan to pay $151M over flawed investment disclosures  ~1 min.

JPMorgan Chase & Co. has agreed to pay a $151 million fine to settle charges that it failed to disclose conflicts of interest to its wealth management clients....

JNJJanuary 2, 2025Talc Baby Powder Lawsuit: January 2025 Settlement Update  ~2 min.

Recent updates on the ongoing Talc Baby Powder Lawsuit against Johnson & Johnson (JNJ) reveal progress towards a possible settlement....